Amgen Inc to sell $1 bln sr notes in two parts-IFR

NEW YORK, March 9 (BestGrowthStock) – Amgen Inc (AMGN.O: ), the
world’s largest biotechnology company, said on Tuesday that it
plans to sell $1 billion of senior notes in a two-part sale,
said IFR, a Thomson Reuters service.

Bank of America Merrill Lynch, Barclays, and Morgan Stanley
are the joint lead bookrunners on the deal, which is set to
price later on Tuesday.

Stock Market Money

(Reporting by Camille Drummond. Editing by W Simon )

Amgen Inc to sell $1 bln sr notes in two parts-IFR